FWM
ARDS

Focused Wealth Management’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Focused Wealth Management’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed – – 1122
2022
Q1 		$0 Hold
100
– – ﹤0.01% 1145
2021
Q4 		$0 Buy
+100
New +$284 ﹤0.01% 1136

Other funds holding ARDS

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Focused Wealth Management's ARDS Position: Q2 2022 in Review

Focused Wealth Management sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q2 2022, closing a stake of 100 shares.

Focused Wealth Management first reported a position in ARDS in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 19 funds tracked by Wall St. Rank hold ARDS as of Q2 2022.

  • Focused Wealth Management reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Focused Wealth Management sold 100 Aridis Pharmaceuticals Inc. Common Stock shares in Q2 2022.
  • Focused Wealth Management first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Focused Wealth Management's Aridis Pharmaceuticals Inc. Common Stock position peaked at $0 in Q1 2022.
  • 19 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q2 2022.

Based on Focused Wealth Management's 13F filing for Q2 2022, filed 4 Aug 2022.